The histological correlates of imaging metrics: postmortem validation of in vivo findings

References

• Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, et al. Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology. 2013;81:2107–15.
   PubMed Web of Science ®Google Scholar
• Machts J, Loewe K, Kaufmann J, Jakubiczka S, Abdulla S, Petri S, et al. Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology. 2015;85:1301–9.
   PubMed Web of Science ®Google Scholar
• Christidi F, Karavasilis E, Velonakis G, Ferentinos P, Rentzos M, Kelekis N, et al. The Clinical and radiological spectrum of hippocampal pathology in amyotrophic lateral sclerosis. Front Neurol. 2018;9:523.
   PubMed Web of Science ®Google Scholar
• Christidi F, Karavasilis E, Rentzos M, Kelekis N, Evdokimidis I, Bede P. Clinical and radiological markers of extra-motor deficits in amyotrophic lateral sclerosis. Front Neurol. 2018;9:1005.
   PubMed Web of Science ®Google Scholar
• Verstraete E, Turner MR, Grosskreutz J, Filippi M, Benatar M. Mind the gap: the mismatch between clinical and imaging metrics in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:524–9.
   PubMed Web of Science ®Google Scholar
• Bede P, Hardiman O. Lessons of ALS imaging: pitfalls and future directions – a critical review. NeuroImage Clin. 2014;4:436–43.
   PubMed Web of Science ®Google Scholar
• Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. NeuroImage. 2005;26:132–40.
   PubMed Web of Science ®Google Scholar
• Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med. 2006;55:302–8.
   PubMed Web of Science ®Google Scholar
• Schuster C, Elamin M, Hardiman O, Bede P. The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration. Eur J Neurol. 2016;23:1361–71.
   PubMed Web of Science ®Google Scholar
• Geser F, Prvulovic D, O’Dwyer L, Hardiman O, Bede P, Bokde ALW, et al. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog Neurobiol. 2011;95:649–62.
   PubMed Web of Science ®Google Scholar
• Saberi S, Stauffer JE, Schulte DJ, Ravits J. Neuropathology of amyotrophic lateral sclerosis and its variants. Neurol Clin. 2015;33:855–76.
   PubMed Web of Science ®Google Scholar
• Bede P, Bokde A, Elamin M, Byrne S, McLaughlin RL, Jordan N, et al. Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality. J Neurol Neurosurg Psychiatry. 2013;84:766–73.
   PubMed Web of Science ®Google Scholar
• Chipika RH, Finegan E, Li Hi Shing S, Hardiman O, Bede P. Tracking a fast-moving disease: longitudinal markers, monitoring, and clinical trial endpoints in ALS. Front Neurol. 2019;10:229.
   PubMed Web of Science ®Google Scholar
• Bede P, Iyer PM, Schuster C, Elamin M, McLaughlin RL, Kenna K, et al. The selective anatomical vulnerability of ALS: 'disease-defining' and 'disease-defying' brain regions. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:561–70.
   PubMed Web of Science ®Google Scholar
• Omer T, Finegan E, Hutchinson S, Doherty M, Vajda A, McLaughlin RL, et al. Neuroimaging patterns along the ALS–FTD spectrum: a multiparametric imaging study. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:611–623.
   PubMed Web of Science ®Google Scholar
• Turner MR, Agosta F, Bede P, Govind V, Lule D, Verstraete E. Neuroimaging in amyotrophic lateral sclerosis. Biomark Med. 2012;6:319–37.
   PubMed Web of Science ®Google Scholar
• Usman U, Choi C, Camicioli R, Seres P, Lynch M, Sekhon R, et al. Mesial prefrontal cortex degeneration in amyotrophic lateral sclerosis: a high-field proton MR spectroscopy study. AJNR Am J Neuroradiol. 2011;32:1677–80.
   PubMed Web of Science ®Google Scholar
• Costagli M, Donatelli G, Biagi L, Caldarazzo Ienco E, Siciliano G, Tosetti M, et al. Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. NeuroImage Clin. 2016;12:965–9.
   PubMed Web of Science ®Google Scholar
• Broad RJ, Gabel MC, Dowell NG, Schwartzman DJ, Seth AK, Zhang H, et al. Neurite orientation and dispersion density imaging (NODDI) detects cortical and corticospinal tract degeneration in ALS. J Neurol Neurosurg Psychiatry 2019;90:404–411.
   PubMed Web of Science ®Google Scholar
• Barritt AW, Gabel MC, Cercignani M, Leigh PN. Emerging magnetic resonance imaging techniques and analysis methods in amyotrophic lateral sclerosis. Front Neurol. 2018;9:1065.
   PubMed Web of Science ®Google Scholar
• Trojsi F, Caiazzo G, Di Nardo F, Fratello M, Santangelo G, Siciliano M, et al. High angular resolution diffusion imaging abnormalities in the early stages of amyotrophic lateral sclerosis. J Neurol Sci. 2017;380:215–22.
   PubMed Web of Science ®Google Scholar
• Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, et al. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study. Brain Imaging Behav. 2018;12:1696.
   PubMed Web of Science ®Google Scholar
• Proudfoot M, Bede P, Turner MR. Imaging cerebral activity in amyotrophic lateral sclerosis. Front Neurol. 2019;9:1148–61.
   PubMed Web of Science ®Google Scholar
• Bede P. Deciphering neurodegeneration: a paradigm shift from focality to connectivity. Neurology 2017;89:1758.
   PubMed Web of Science ®Google Scholar
• Geevasinga N, Korgaonkar MS, Menon P, Van den Bos M, Gomes L, Foster S, et al. Brain functional connectome abnormalities in amyotrophic lateral sclerosis are associated with disability and cortical hyperexcitability. Eur J Neurol. 2017;24:1507–17.
   PubMed Web of Science ®Google Scholar
• Johns SLM, Ishaque A, Khan M, Yang YH, Wilman AH, Kalra S. Quantifying changes on susceptibility weighted images in amyotrophic lateral sclerosis using MRI texture analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;1–8. [Epub ahead of print]. doi: 10.1080/21678421.2019.1599024
   Google Scholar
• Ratai EM, Alshikho MJ, Zurcher NR, Loggia ML, Cebulla CL, Cernasov P, et al. Integrated imaging of [(11)C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy (1)H-MRS in amyotrophic lateral sclerosis. NeuroImage Clin. 2018;20:357–64.
   PubMed Web of Science ®Google Scholar
• Querin G, Mendili MM E, Bede P, Delphine S, Lenglet T, Marchand-Pauvert V, et al. Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. J Neurol Neurosurg Psychiatry 2018;89:1220–1221.
   PubMed Web of Science ®Google Scholar
• Bede P, Bokde AL, Byrne S, Elamin M, Fagan AJ, Hardiman O. Spinal cord markers in ALS: diagnostic and biomarker considerations. Amyotroph Lateral Scler. 2012;13:407–15.
   PubMed Web of Science ®Google Scholar
• El Mendili MM, Querin G, Bede P, Pradat PF. Spinal cord imaging in amyotrophic lateral sclerosis: historical concepts – novel techniques. Front Neurol. 2019;10:350.
   PubMed Web of Science ®Google Scholar
• Bede P, Querin G, Pradat PF. The changing landscape of motor neuron disease imaging: the transition from descriptive studies to precision clinical tools. Curr Opin Neurol. 2018;31:431–8.
   PubMed Web of Science ®Google Scholar
• Finegan E, Chipika RH, Shing SLH, Hardiman O, Bede P. Primary lateral sclerosis: a distinct entity or part of the ALS spectrum? Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:133–145.
   PubMed Web of Science ®Google Scholar
• Clark MG, Smallwood SR, Huang CJ, Danielian LE, Bageac D, Floeter MK. Loss of functional connectivity is an early imaging marker in primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:562–9.
   PubMed Web of Science ®Google Scholar
• Evans MC, Modo M, Talbot K, Sibson N, Turner MR. Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012;13:288–301.
   PubMed Web of Science ®Google Scholar
• Pallebage-Gamarallage M, Foxley S, Menke RAL, Huszar IN, Jenkinson M, Tendler BC, et al. Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: a post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology. BMC Neurosci. 2018;19:11.
   PubMed Web of Science ®Google Scholar
• Cardenas AM, Sarlls JE, Kwan JY, Bageac D, Gala ZS, Danielian LE, et al. Pathology of callosal damage in ALS: an ex-vivo, 7T diffusion tensor MRI study. NeuroImage Clin. 2017;15:200–8.
   PubMed Web of Science ®Google Scholar
• Kwan JY, Jeong SY, Van Gelderen P, Deng HX, Quezado MM, Danielian LE, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 Tesla MRI and pathology. PLoS One. 2012;7:e35241.
   PubMed Web of Science ®Google Scholar
• Menke RA, Proudfoot M, Wuu J, Andersen PM, Talbot K, Benatar M, et al. Increased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic risk. J Neurol Neurosurg Psychiatry. 2016;87:580–8.
   PubMed Web of Science ®Google Scholar
• Turner MR, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ, et al. Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET. Brain J Neurol. 2005;128:1323–9.
   Google Scholar
• Floeter MK, Danielian LE, Braun LE, Wu T. Longitudinal diffusion imaging across the C9orf72 clinical spectrum. J Neurol Neurosurg Psychiatry. 2018;89:53–60.
   PubMed Web of Science ®Google Scholar
• Floeter MK, Traynor BJ, Farren J, Braun LE, Tierney M, Wiggs EA, et al. Disease progression in C9orf72 mutation carriers. Neurology 2017;89:234–41.
   PubMed Web of Science ®Google Scholar
• Papma JM, Jiskoot LC, Panman JL, Dopper EG, den Heijer T, Donker Kaat L, et al. Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion. Neurology 2017;89:1256–64.
   PubMed Web of Science ®Google Scholar
• Wen J, Zhang H, Alexander DC, Durrleman S, Routier A, Rinaldi D, et al. Neurite density is reduced in the presymptomatic phase of C9orf72 disease. J Neurol Neurosurg Psychiatry. 2019;90:387–94.
   PubMed Web of Science ®Google Scholar
• Bertrand A, Wen J, Rinaldi D, Houot M, Sayah S, Camuzat A, et al. Early cognitive, structural, and microstructural changes in presymptomatic C9orf72 carriers younger than 40 years. JAMA Neurol. 2018;75:236–45.
   PubMed Web of Science ®Google Scholar
• Bede P, Bokde ALW, Byrne S, Elamin M, McLaughlin RL, Kenna K, et al. Multiparametric MRI study of ALS stratified for the C9orf72 genotype. Neurology 2013;81:361–9.
   PubMed Web of Science ®Google Scholar
• Querin G, Bede P, El Mendili MM, Li M, Pelegrini-Issac M, Rinaldi D, et al. Presymptomatic spinal cord pathology in c9orf72 mutation carriers: a longitudinal neuroimaging study. Ann Neurol. 2019 Jun 8. [Epub ahead of print]. doi:10.1002/ana.25520
   Web of Science ®Google Scholar
• Benatar M, Wuu J. Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology 2012;79:1732–9.
   PubMed Web of Science ®Google Scholar
• Schuster C, Elamin M, Hardiman O, Bede P. Presymptomatic and longitudinal neuroimaging in neurodegeneration–from snapshots to motion picture: a systematic review. J Neurol Neurosurg Psychiatry. 2015;86:1089–96.
   PubMed Web of Science ®Google Scholar
• Benatar M, Turner MR, Wuu J. Defining pre-symptomatic amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Mar 20:1–7. [Epub ahead of print]. doi: 10.1080/21678421.2019.1587634
   Web of Science ®Google Scholar